As­traZeneca en­ters pre­clin­i­cal cell ther­a­py deal with Cana­di­an biotech

Cana­di­an cell ther­a­py biotech Ser­no­va an­nounced a pre­clin­i­cal re­search deal with As­traZeneca that will see how Ser­no­va’s im­plantable med­ical de­vice works in com­bi­na­tion with cell …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER